SenesTech

SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations, primarily rat populations through fertility control. It offers its ContraPest product to residential, and commercial sectors such as animal, structural, and food markets. The company was founded by Loretta P. Mayer and Cheryl A. Dyer on July 27, 2004 and is headquartered in Phoenix, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

SenesTech reports record revenue growth driven by Evolve product launch

SenesTech's Q1 2024 performance was driven by the successful launch of Evolve, leading to record revenue growth. The company's strengths lie in expanding distribution channels and focusing on operational efficiencies. Challenges include achieving positive cash flow and balancing sales channels, while opportunities exist in capturing a larger market share with Evolve mouse and leveraging the Amazon store launch.

SenesTech achieves record revenue and margin growth, eyes global expansion

SenesTech delivered strong financial performance with record revenue and improved margins.
The company's product portfolio and expansion strategies position it for continued growth.
Challenges include maintaining profitability, managing competition, and balancing growth with financial stability.
Opportunities exist in market penetration, partnerships, and global expansion initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations. The firm focuses on rat populations through fertility control. It offers its ContraPest product to residential and commercial sectors such as animal, structural, and food markets. The company was founded by Loretta P. Mayer and Cheryl A. Dyer on July 27, 2004 and is headquartered in Phoenix, AZ.

SenesTech, Inc. (NASDAQ:SNES ) Q3 2024 Earnings Conference Call November 12, 2024 5:00 PM ET Company Participants Robert Blum - Lytham Partners Joel Fruendt - Chief Executive Officer Tom Chesterman - Chief Financial Officer Operator Good day and welcome to the SenesTech Third Quarter Fiscal Year 2024 Financial Results Conference Call. All participants will be in a listen-only mode for the duration of the call.

SenesTech, Inc. (SNES) Q3 2024 Earnings Call Transcript

Record Revenue and Margin Performance PHOENIX , Nov. 12, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations and the only manufacturer of commercial and consumer available EPA-registered Rat Birth Control® products today announced financial results for the third quarter of 2024. Recent Highlights Revenues of $1.4 million in the first nine months of 2024, an increase of 51% compared to the same period of 2023.

SenesTech Announces Third Quarter 2024 Financial Results

Significantly Expanding Market Reach PHOENIX , Nov. 12, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), a leader in fertility control solutions for managing animal pest populations, is excited to announce a significant expansion in the distribution of its groundbreaking rodent birth control product. Evolve™ Rat and Evolve™ Mouse are now available on Walmart Marketplace, one of the largest and most trusted eCommerce platforms in the world.

SenesTech Launches Evolve™ Rodent Birth Control on Walmart Marketplace

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX , Nov. 5, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its third quarter 2024, ended September 30, 2024, after the market close on Tuesday, November 12, 2024. The Company has scheduled a conference call that same day, Tuesday, November 12, 2024, at 5:00 pm ET, to review the results.

SenesTech to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

PHOENIX , Oct. 31, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), the leader in birth control to manage rodent pest populations, today announces the successful registration of Evolve™ in Hong Kong. A Sustainable and Humane Approach to Rodent Control Hong Kong welcomes Evolve™, an innovative, non-lethal rodent birth control solution designed to target rat infestations at their root.

Evolve™ Registered in Hong Kong; Offering a Revolutionary Non-Lethal Rodent Control Solution

PHOENIX , Oct. 8, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), the leader in birth control to manage rodent pest populations, today announces that the New York City Council has approved a bill to implement a rat contraception pilot program. From the bill, the term "rat contraceptive" means an agent for the reduction of reproductive capacity in rats that is approved for such use by the United States Environment Protection Agency.

New York City to Pursue Rat Contraception Pilot Program

PHOENIX , Sept. 23, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced today it will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2024 Investor Conference, taking place virtually on Tuesday, October 1, 2024.

SenesTech to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024

PHOENIX , Aug. 23, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced today the closing of an exercise of certain existing warrants to purchase 505,502 shares of the Company's common stock at a reduced exercise price of $4.60 per share. In addition, the Company issued new warrants, as described below.

SenesTech Announces Closing of Warrant Exercise for $2.3 Million in Gross Proceeds

SenesTech, Inc. (NASDAQ:SNES ) Q2 2024 Earnings Conference Call August 8, 2024 5:00 PM ET Company Participants Robert Blum – Lytham Partners Joel Fruendt – Chief Executive Officer Tom Chesterman – Chief Financial Officer Conference Call Participants Operator Good afternoon, and welcome to the SenesTech Reports Second Quarter Fiscal Year 2024 Results. [Operator Instructions] Please note this event is being recorded.

SenesTech, Inc. (SNES) Q2 2024 Earnings Call Transcript

Record Revenue and Margin Performance PHOENIX , Aug. 8, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control® products today announced financial results for the second quarter of 2024. Recent Highlights Record revenues of $874,000 in the first half of 2024, an increase of 62% compared to the first half of 2023.

SenesTech Announces Second Quarter 2024 Financial Results

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX , Aug. 1, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its second quarter 2024, ended June 30, 2024, after the market close on Thursday, August 8, 2024. The Company has scheduled a conference call that same day, Thursday, August 8, 2024, at 5:00 pm ET, to review the results.

SenesTech to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

Common Stock Will Begin Trading on a Split-Adjusted Basis on July 25, 2024 PHOENIX , July 23, 2024 /PRNewswire/ -- SenesTech, Inc.  (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com) the leader in fertility control to manage animal pest populations, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 10 pre-split shares. The reverse stock split will become effective at 4:01 p.m, Eastern Time, on July 24, 2024.

SenesTech Announces Reverse Stock Split

PHOENIX , June 26, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announced that Evolve™, the Company's minimum risk soft bait for the proactive control of rats, will be deployed in the U.S Virgin Islands as part of an international effort to control invasive species in environmentally sensitive areas. This effort is administered by the Wild Ecology Group.

SenesTech's Evolve™ Fertility Control Solution for Rats To Be Deployed in the U.S. Virgin Islands

SenesTech (SNES) looks to leverage the convenience and reach of e-commerce to expand its market share.

SenesTech (SNES) to Gain Market With Evolve's Launch on Amazon

PHOENIX , May 23, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) today announced that Joel Fruendt, Chief Executive Officer, and Tom Chesterman, Chief Financial Officer, will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2024 Investor Conference, taking place virtually on Thursday, May 30, 2024. Company Webcast The webcasted presentation will take place at 11:45am ET on Thursday, May 30, 2024.

SenesTech to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

PHOENIX , May 22, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announced that it has taken a significant step forward in the distribution of EvolveTM, the Company's minimum risk soft bait for the proactive control of rats, through the launch of a dedicated online store on Amazon, the world's largest online retailer. To purchase Evolve on Amazon, please visit this link.

SenesTech Launches Evolve™ Fertility Control Solution for Rats on Amazon, the World's Largest Online Retailer

SenesTech, Inc. (NASDAQ:SNES ) Q1 2024 Earnings Conference Call May 9, 2024 5:00 PM ET Company Participants Robert Blum - Investor Relations, Lytham Partners Joel Fruendt - Chief Executive Officer Tom Chesterman - Chief Financial Officer Conference Call Participants Operator Good day and welcome to the SenesTech Inc. Reports First Quarter Fiscal Year 2024 Financial Results Conference Call. All participants will be in a listen only mode.

SenesTech, Inc. (SNES) Q1 2024 Earnings Call Transcript

PHOENIX , May 9, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control® products today announced financial results for the first quarter of 2024. Recent Highlights Record quarterly revenues during Q1 2024 of $415,000, an increase of 78% compared to Q1 2023.

SenesTech Announces First Quarter 2024 Financial Results

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX , May 2, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its first quarter 2024, ended March 31, 2024, after the market close on Thursday, May 9, 2024. The Company has scheduled a conference call that same day, Thursday, May 9, 2024, at 5:00 pm ET, to review the results.

SenesTech to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

A Revolutionary Soft Bait to Control Mouse Populations PHOENIX , May 2, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces that the Company has launched Evolve™ Mouse, utilizing a breakthrough fertility control solution, for the control of mouse infestations. Evolve Mouse is designated as a 'minimum risk' product by the U.S. Environmental Protection Agency, posing little to no risk to human health and the environment.

SenesTech Launches Evolve™ Mouse

Webcasted presentation to take place at 3:10pm ET PHOENIX , April 2, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, today announced that its Chief Executive Officer, Joel Fruendt, will be participating in the Emerging Growth Conference. Mr. Fruendt's presentation will be on Wednesday, April 3, 2024 at 3:10pm ET.

SenesTech to Present at the Emerging Growth Conference on April 3, 2024

PHOENIX , March 26, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces a signed distribution agreement with Wilco Distributors Inc., a distributor of pest management baits and tools to the rodent pest management market. Wilco Distributors will be a stocking distributor for Evolve™ soft bait and has placed its initial multi-pallet stocking order.

SenesTech Signs Wilco Distributing for Evolve™ and ContraPest® Distribution in Agriculture and Professional Rodent Pest Management Market

Webcasted presentation to take place at 1:10pm ET PHOENIX , March 5, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) today announced that the Company will be participating in the Emerging Growth Conference on March 6, 2024. Management will deliver a webcasted presentation and subsequently open the floor to questions during the Conference.

SenesTech to Present at the Emerging Growth Conference on March 6, 2024

SenesTech, Inc. (SNES) Q4 2023 Earnings Call Transcript

YTD 2024 total revenue up more than 80% compared to YTD 2023 driven by orders for Evolve™ soft bait PHOENIX , Feb. 21, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced 2023 financial results. "During 2023, we executed on a number of key initiatives that will be the foundation to drive growth into the future, most notably was the development of Evolve, our all-new soft bait product that was launched on a limited basis at the end of 2023," commented Joel Fruendt, President and CEO of SenesTech.

News for SenesTech Stock (SNES)